All In MedTech

FDA Clearance Tracker · P170043-S020

iStent inject Trabecular MicroBypass System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P170043-S020
Device name
iStent inject Trabecular MicroBypass System
Applicant location
San Clemente, CA
Received
Jul 18, 2024
Decided
Jan 13, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P170043

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

Request for approval of labeling changes made to the Directions for Use and Package Insert.

Source documents

Other decisions for Glaukos Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.